NewsBenzinga阿斯利康周六宣布，在一线广泛期小细胞肺癌的 DeLLphi-305 III 期研究中，IMFINZI 联合 Tarlatamab-dlle 相比单用 IMFINZI 可将死亡风险降低 58%，中位总生存期分别为 21.1 个月和 12.7 个月。 阿斯利康周六宣布，在一线广泛期小细胞肺癌的 DeLLphi-305 III 期研究中，IMFINZI 联合 Tarlatamab-dlle 相比单用 IMFINZI 可将死亡风险降低 58%，中位总生存期分别为 21.1 个月和 12.7 个月。 Benzinga 2026.10.26 07:00 (GMT+0) Open on Benzinga Other news Support for semiconductor stocks could be as much as 15% lower than current levels, says Morgan Stanley Amcor’s Quarterly Earnings Preview: What You Need to Know Trader kimchi Adds Pump.fun Back to His Bio Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity Trader Mk4's NEAR long shows $12.15M unrealized profit, long position worth over $25M Baron Health Care Fund Q3 2026 Top Contributors And Detractors
Support for semiconductor stocks could be as much as 15% lower than current levels, says Morgan Stanley
Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity
